Molecular Dynamics in discovery deal with SmithKline Beecham:
This article was originally published in Clinica
Molecular Dynamics is to develop high-throughput instrumentation for SmithKline Beecham to speed up diagnostic discovery and development. Under the terms of the deal, SK-B will provide capital in exchange for early access to Molecular Dynamics' latest laser fluorescence confocal scanning technology.
You may also be interested in...
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.